Kurnit KC - Search Results

1

CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas.

Hirsch RM, Premsankar S, Kurnit KC, Chiou LF, Rabjohns EM, Lee HN, Broaddus RR, Vaziri C, Bowser JL. Hirsch RM, et al. Among authors: kurnit kc. bioRxiv [Preprint]. 2024 Nov 18:2024.11.18.624183. doi: 10.1101/2024.11.18.624183. bioRxiv. 2024. PMID: 39605508 Free PMC article. Preprint.

2

Primary gynecologic lymphoma when diagnosed by a gynecologist: A case series.

Lamacki AJ, Montag C, Kertowidjojo E, Diane Yamada S, Kurnit KC. Lamacki AJ, et al. Among authors: kurnit kc. Gynecol Oncol Rep. 2024 May 4;53:101409. doi: 10.1016/j.gore.2024.101409. eCollection 2024 Jun. Gynecol Oncol Rep. 2024. PMID: 38757117 Free PMC article.

3

Harnessing Antitumor Immunity in Ovarian Cancer.

Kurnit KC, Odunsi K. Kurnit KC, et al. Cold Spring Harb Perspect Med. 2024 Dec 2;14(12):a041336. doi: 10.1101/cshperspect.a041336. Cold Spring Harb Perspect Med. 2024. PMID: 38621830 Review.

4

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.

Disis ML, Adams SF, Bajpai J, Butler MO, Curiel T, Dodt SA, Doherty L, Emens LA, Friedman CF, Gatti-Mays M, Geller MA, Jazaeri A, John VS, Kurnit KC, Liao JB, Mahdi H, Mills A, Zsiros E, Odunsi K. Disis ML, et al. Among authors: kurnit kc. J Immunother Cancer. 2023 Jun;11(6):e006624. doi: 10.1136/jitc-2022-006624. J Immunother Cancer. 2023. PMID: 37295818 Free PMC article.

5

Stranger Things: New Roles and Opportunities for Androgen Receptor in Oncology Beyond Prostate Cancer.

Leo J, Dondossola E, Basham KJ, Wilson NR, Alhalabi O, Gao J, Kurnit KC, White MG, McQuade JL, Westin SN, Wellberg EA, Frigo DE. Leo J, et al. Among authors: kurnit kc. Endocrinology. 2023 Apr 17;164(6):bqad071. doi: 10.1210/endocr/bqad071. Endocrinology. 2023. PMID: 37154098 Free PMC article. Review.

6

Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study.

Kurnit KC, Nobre SP, Fellman BM, Iglesias DA, Lindemann K, Jhingran A, Eriksson AGZ, Ataseven B, Glaser GE, Mueller JJ, Westin SN, Soliman PT. Kurnit KC, et al. Gynecol Oncol. 2022 Dec;167(3):452-457. doi: 10.1016/j.ygyno.2022.09.025. Epub 2022 Oct 13. Gynecol Oncol. 2022. PMID: 36243601 Free PMC article.

7

Primary mucinous ovarian cancer: options for surgery and chemotherapy.

Kurnit KC, Frumovitz M. Kurnit KC, et al. Int J Gynecol Cancer. 2022 Oct 13:ijgc-2022-003806. doi: 10.1136/ijgc-2022-003806. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 36229081 Review.

8

Molecular Characterizations of Gynecologic Carcinosarcomas: A Focus on the Immune Microenvironment.

Nakad Borrego S, Lengyel E, Kurnit KC. Nakad Borrego S, et al. Among authors: kurnit kc. Cancers (Basel). 2022 Sep 14;14(18):4465. doi: 10.3390/cancers14184465. Cancers (Basel). 2022. PMID: 36139624 Free PMC article. Review.

9

High glucocorticoid receptor expression in the sarcomatous versus carcinomatous elements of Mullerian carcinosarcomas.

Kurnit KC, Steiner M, Lastra RR, Weroha SJ, Cursio J, Lengyel E, Fleming GF, Conzen SD. Kurnit KC, et al. Gynecol Oncol Rep. 2022 Apr 27;41:100987. doi: 10.1016/j.gore.2022.100987. eCollection 2022 Jun. Gynecol Oncol Rep. 2022. PMID: 35519002 Free PMC article.

10

Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.

Kurnit KC, Fellman BM, Mills GB, Bowser JL, Xie S, Broaddus RR. Kurnit KC, et al. Int J Gynecol Cancer. 2022 Jul 4;32(7):869-874. doi: 10.1136/ijgc-2021-003340. Int J Gynecol Cancer. 2022. PMID: 35483739 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters